{"id":"CHEMBL1126","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"FCPVYOBCFFNJFS-LQDWTQKMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN G SODIUM","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Penicillin g sodium"],"synonyms":["Benzyl penicillin sodium","Benzylpenicillin sodium","Benzylpenicillinum natricum","Crystapen","E706","Ethacillin","Monocillin","NSC-402815","Penicillin G Sodium","Penicillin g sodium","Penicillin g sodium salt","Penicillin g sodium, crystalline","Penicillin sodium","Penicillinum","Sodium benzylpenicillinoate"],"crossReferences":{"DailyMed":["penicillin%20g%20sodium"],"PubChem":["11112931"],"chEBI":["51765"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL114070","canonicalSmiles":"O=[N+]([O-])c1cccc([N+](=O)[O-])c1","inchiKey":"WDCYWAQPCXBPJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINITROPHENYLENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,3 Dinitrobenzene","1,3-Dinitro-Benzene"],"crossReferences":{"PubChem":["144204670","144213993","17388932","26752980"],"drugbank":["DB02680"],"chEBI":["51397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160965","canonicalSmiles":"N[C@@H](Cc1ccccc1)C(=O)NCCOCCOCCNC(=O)c1ccc(S(N)(=O)=O)cc1","inchiKey":"QNZDHHNWUXIYOH-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07710"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1183627","canonicalSmiles":"NCCC(=O)NCCSSCCNC(=O)CCN","inchiKey":"WELIVEBWRWAGOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALETHINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-alethine","Alethine","Alethine, beta-","Beta alethine","Beta-alethine","Betathine"],"crossReferences":{"drugbank":["DB05800"]},"childChemblIds":["CHEMBL308230"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1187417","canonicalSmiles":"CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1","inchiKey":"VVZBFOKBSDGVGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENZALKONIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzalkonium","Benzalkonium cation","Benzalkonium ion"],"childChemblIds":["CHEMBL502109"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL119","canonicalSmiles":"COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC","inchiKey":"NOYPYLRCIDNJJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETREXATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CI-898","NSC-249008","Neutrexin","Trimetrexate"],"crossReferences":{"PubChem":["26755046","50110873"],"Wikipedia":["Trimetrexate"],"drugbank":["DB01157"]},"childChemblIds":["CHEMBL2218878","CHEMBL3392303","CHEMBL2358886"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 4 investigational indications."}
{"id":"CHEMBL1193948","canonicalSmiles":"CCOC(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2","inchiKey":"RDJQCOBTKKAQAH-FPOVZHCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIBEGRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amibegron","SR-58611","SR58611"],"crossReferences":{"drugbank":["DB05395"]},"childChemblIds":["CHEMBL545437"],"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0005230"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1200596","canonicalSmiles":"Oc1c(Cl)cc(Cl)c2cccnc12","inchiKey":"WDFKMLRRRCGAKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROXINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capitrol"],"synonyms":["Chloroxine","NSC-3904"],"crossReferences":{"PubChem":["144205047","170465084","174006956","24715093","24715133","24813759","26749233"],"Wikipedia":["Chloroxine"],"drugbank":["DB01243"],"chEBI":["59477"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1200681","canonicalSmiles":"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)[O-])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1.[Na+]","inchiKey":"LBFBRXGCXUHRJY-HKHDRNBDSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"MONTELUKAST SODIUM","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL787","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Montelukast sodium","Singulair"],"synonyms":["MK-476","Montelukast (as sodium)","Montelukast monosodium salt","Montelukast sodium","NSC-759107"],"crossReferences":{"DailyMed":["montelukast%20sodium"],"PubChem":["144205750","170465230","56320471"],"chEBI":["6993"]},"linkedTargets":{"rows":["ENSG00000173198"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0008521","EFO_0007183","EFO_0010638","HP_0011950","EFO_0009836","EFO_0004232","HP_0100806","MONDO_0100096","HP_0040187","MONDO_0004979","EFO_0000341","EFO_1001417","EFO_0003918","EFO_0005672","EFO_0003956"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 4 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201048","canonicalSmiles":"CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"NOTIQUSPUUHHEH-UXOVVSIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROMOSTANOLONE PROPIONATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Drolban","Masteril"],"synonyms":["32379","Dromostanolone","Dromostanolone propionate","Drostanolone","Drostanolone propionate","Masterid","Masteron","NSC-12198","NSC-1298","Permastril"],"crossReferences":{"drugbank":["DB14655"],"chEBI":["31523"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201217","canonicalSmiles":"CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1","inchiKey":"BZEWSEKUUPWQDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DYCLONINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dyclonine"],"crossReferences":{"DailyMed":["dyclonine%20hydrochloride"],"PubChem":["11112403","50100427"],"Wikipedia":["Dyclonine"],"drugbank":["DB00645"],"chEBI":["4724"]},"childChemblIds":["CHEMBL1200478"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201290","canonicalSmiles":"[K]","inchiKey":"ZLMJMSJWJFRBEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Potassium"],"crossReferences":{"chEBI":["26216"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1229868","canonicalSmiles":"O=C(NO)C1(S(=O)(=O)c2ccc(Oc3ccc(C(F)(F)F)cc3)cc2)CCOCC1","inchiKey":"FOSWRYKPHVPIDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-77774","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-77774"],"crossReferences":{"drugbank":["DB06945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230001","canonicalSmiles":"O=C(O)c1ccccc1NC(=O)N1CCC(c2ccccc2C(F)(F)F)CC1","inchiKey":"MEAQCLPMSVEOQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06985"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232993","drugType":"Small molecule","blackBoxWarning":false,"name":"GADOLINIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gadolinium"],"crossReferences":{"chEBI":["33375"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1234593","canonicalSmiles":"CC(C)c1nc2c(OCC3CCCCC3)nc(N)nc2[nH]1","inchiKey":"JABXNQUXGJTKRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234593","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08247"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235140","canonicalSmiles":"C[C@@]1(O)OC[C@H](O)C1(O)O","inchiKey":"BVIYGXUQVXBHQS-IUYQGCFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235140","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04346"],"chEBI":["44800"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235246","canonicalSmiles":"CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O","inchiKey":"HVAUUPRFYPCOCA-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235246","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26754980","26754981"],"drugbank":["DB02261"],"chEBI":["44811"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255891","canonicalSmiles":"CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1","inchiKey":"RICZEKWVNZFTNZ-LFGITCQGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARLAPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Narlaprevir","SCH 900518","SCH-900518"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1284","canonicalSmiles":"O=C(O)Cc1ccc(O)c(O)c1","inchiKey":"CFFZDZCDUFSOFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4-DIHYDROXYPHENYLACETIC ACID ","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DOPAC"],"crossReferences":{"PubChem":["11111112","124879971","26732626","26753554","50106188","85231019","90341470"],"Wikipedia":["3,4-Dihydroxyphenylacetic_acid"],"drugbank":["DB01702"],"chEBI":["41941"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1287935","canonicalSmiles":"CC[C@H](Nc1cc(C)nc2c(-c3ccc(OC)cc3C)c(C)nn12)c1nc(C)no1","inchiKey":"VKHVAUKFLBBZFJ-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERUCERFONT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-561,679","GSK-561679","GSK-561679A","GSK561679","GSK561679A","NBI-77860","Verucerfont"],"crossReferences":{"drugbank":["DB12512"]},"linkedTargets":{"rows":["ENSG00000120088"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0000555","EFO_0001358","EFO_1001917","MONDO_0007079","Orphanet_418"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1393","canonicalSmiles":"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21","inchiKey":"LXMSZDCAJNLERA-ZHYRCANASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SPIRONOLACTONE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abbolactone","Aldactone","Carospir","Diatensec","Gx spironol","Laractone","Spiretic","Spiroctan 100","Spiroctan 25","Spiroctan 50","Spironolactone","Spirospare 100","Spirospare 25"],"synonyms":["NSC-150399","SC-9420","Spironolactone","Spironolactone ceva","Spironolactonum","Verospirone"],"crossReferences":{"DailyMed":["spironolactone"],"PubChem":["144206598","144212471","26757816","47193741"],"Wikipedia":["Spironolactone"],"drugbank":["DB00421"],"chEBI":["9241"]},"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["HP_0001397","EFO_0001361","EFO_1000710","MONDO_0100130","EFO_0000275","EFO_0001365","EFO_0000401","EFO_1001249","EFO_0005669","EFO_0000373","EFO_0000266","EFO_1002048","EFO_0000565","EFO_0003914","Orphanet_247","EFO_0008585","EFO_0003144","EFO_0003884","MONDO_0000088","EFO_0004255","EFO_0004616","EFO_0000400","EFO_0008586","EFO_1000802","EFO_0000694","EFO_0000685","MONDO_0005149","EFO_0010133","EFO_0003963","HP_0001919","EFO_0000222","EFO_0000319","EFO_0003894","EFO_1001496","EFO_0000660","EFO_0000537","EFO_0000311","Orphanet_98896","EFO_0001422","EFO_0004517","EFO_1001482","MONDO_0001134","MONDO_0100096","HP_0004308","EFO_0000574","EFO_1001207","EFO_1000766","HP_0012424","EFO_0000612","HP_0001943","EFO_0003918","EFO_0004191","EFO_0000668","EFO_1000899"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 8 approved and 28 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1406148","canonicalSmiles":"CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC","inchiKey":"VLPFTAMPNXLGLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICAPRILIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC-1202","AC-1204","Axona","CER-0001","Caprylic acid triglyceride","Caprylic triglyceride","Glyceryl tricaprylate","Miglyol 808","NSC-4059","Tricaprilin","Tricaprylic glyceride","Tricaprylin"],"crossReferences":{"PubChem":["144204661","144208678","144213079","170465841","17389701","85148784"],"drugbank":["DB12176"],"chEBI":["76978"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1455","canonicalSmiles":"CN(C)c1nc(N(C)C)nc(N(C)C)n1","inchiKey":"UUVWYPNAQBNQJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALTRETAMINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hexalen","Hexastat"],"synonyms":["Altretamine","Hexamethylmelamine","NSC-13875"],"crossReferences":{"PubChem":["11110789","11110790","144203636","144209982","170464714","174006220","50103890","56422107","78208","85230922","855523","90341558"],"Wikipedia":["Altretamine"],"drugbank":["DB00488"],"chEBI":["24564"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for neoplasm and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1482","canonicalSmiles":"CC(C[N+](C)(C)C)OC(N)=O","inchiKey":"NZUPCNDJBJXXRF-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"BETHANECHOL","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bethanechol"],"crossReferences":{"DailyMed":["bethanechol%20chloride"],"PubChem":["124879661","26756574","90341349"],"Wikipedia":["Bethanechol"],"drugbank":["DB01019"],"chEBI":["3084"]},"childChemblIds":["CHEMBL1768"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0004232","EFO_0002618","HP_0000016","MONDO_0005148"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and is indicated for urinary retention and has 3 investigational indications."}
{"id":"CHEMBL1510","canonicalSmiles":"CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12","inchiKey":"PWVXXGRKLHYWKM-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELETRIPTAN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Relpax"],"synonyms":["Eletriptan","UK-116,044","UK-116,044-04 FREE BASE","UK-116,044-04 [AS HYDROBROMIDE)","UK-116044","UK-116044-04","UK-116044-04 FREE BASE"],"crossReferences":{"DailyMed":["eletriptan%20hydrobromide"],"PubChem":["144206290","170465317","50125841"],"Wikipedia":["Eletriptan"],"drugbank":["DB00216"],"chEBI":["50922"]},"childChemblIds":["CHEMBL1201003"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546","ENSG00000179097"],"count":3},"linkedDiseases":{"rows":["MONDO_0100431","MONDO_0005277","MONDO_0005475"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL151958","canonicalSmiles":"Cc1c(CNc2cccc3ncccc23)cnc2nc(N)nc(N)c12","inchiKey":"KMSATRJZEXNGDP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL151958","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03351"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL153057","canonicalSmiles":"CCCc1c(OCCCOc2ccc(OCC(=O)O)cc2)ccc(C(C)=O)c1O","inchiKey":"HBBVCKCCQCQCTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-165041","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-165041"],"crossReferences":{"PubChem":["11111371","124880537","144212730","26753592","50106426","50106427","56463274","85231109","90341011"],"drugbank":["DB08078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1608558","canonicalSmiles":"CN=C=O","inchiKey":"HAMGRBXTJNITHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1608558","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208258","17388916"],"drugbank":["DB12765"],"chEBI":["59059"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1652442","canonicalSmiles":"Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"OAKKJVUSSVZQRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAQUINE TETRAPHOSPHATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL303933","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piperaquine Phosphate","Piperaquine tetraphosphate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1697845","canonicalSmiles":"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"ZDHCJEIGTNNEMY-XGXHKTLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORETHANDROLONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-70581","Nilevar","Norethandrolone","Pronabol","Solevar"],"crossReferences":{"drugbank":["DB12787"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1767407","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)O2)c(=O)n1.[Na+].[Na+].[Na+].[Na+]","inchiKey":"PASYJVRFGUDDEW-WMUGRWSXSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"DENUFOSOL TETRASODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL507282","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denufosol tetrasodium","Denufosol tetrasodium salt","INS-37217","INS37217"],"linkedTargets":{"rows":["ENSG00000175591"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","Orphanet_586","EFO_0005773","EFO_1001417"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL177","canonicalSmiles":"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O","inchiKey":"LKCWBDHBTVXHDL-RMDFUYIESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMIKACIN","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amikacin","Amikacinum","Amikin","BAY 41-6551","Lukadin","NSC-177001","Potentox"],"crossReferences":{"DailyMed":["amikacin%20sulfate"],"PubChem":["144204752","170465345","29215141"],"Wikipedia":["Amikacin"],"drugbank":["DB00479"],"chEBI":["2637"]},"childChemblIds":["CHEMBL1879513","CHEMBL4208954","CHEMBL4303360","CHEMBL1164318"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 9 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL178862","canonicalSmiles":"COc1ccc(-c2cc(=S)ss2)cc1","inchiKey":"KYLIZBIRMBGUOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANETHOLTRITHION","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anethole Trithione","Anethole trithione","Anetholtrithion","OP-2113","OP2113"],"crossReferences":{"PubChem":["144206028","170465669","50112725"],"Wikipedia":["Anethole_trithione"],"drugbank":["DB13853"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180071","canonicalSmiles":"Oc1ccc(-n2nc3ccc(O)cc3c2Cl)cc1","inchiKey":"ZNHQDSBJVFFIAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180071","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07708"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180672","canonicalSmiles":"CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N","inchiKey":"PZUJQWHTIRWCID-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NPS-2143","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NPS-2143","SB-262470"],"crossReferences":{"drugbank":["DB05695"]},"childChemblIds":["CHEMBL2112075"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL184238","canonicalSmiles":"NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1","inchiKey":"ROFVXGGUISEHAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URB-597","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KDS-4103","ORG-231295","URB 597","URB597","Urb-597"],"crossReferences":{"PubChem":["174007488","29217673","47204541"],"Wikipedia":["URB597"]},"childChemblIds":["CHEMBL2314117"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL189963","canonicalSmiles":"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O","inchiKey":"AHJRHEGDXFFMBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALBOCICLIB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ibrance"],"synonyms":["PD-0332991","Palbociclib"],"crossReferences":{"DailyMed":["palbociclib"],"PubChem":["103905660","103905661","137275973"],"drugbank":["DB09073"],"chEBI":["85993"]},"childChemblIds":["CHEMBL2364621","CHEMBL3962672"],"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003869","EFO_0000756","MONDO_0007254","EFO_1001469","EFO_0005952","EFO_0000708","EFO_0004252","EFO_0000228","EFO_0000305","EFO_0000632","Orphanet_178","EFO_1001480","MONDO_0008903","EFO_0000182","EFO_0008528","EFO_0002626","EFO_0000707","EFO_1000045","EFO_0000616","EFO_0002618","Orphanet_145","EFO_0006859","EFO_0006318","EFO_0000220","MONDO_0008170","EFO_0000349","EFO_0000222","EFO_1001968","MONDO_0004379","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0000630","EFO_0000174","EFO_0002517","MONDO_0011962","EFO_0000574","EFO_0001378","MONDO_0024880","EFO_1001950","EFO_0000181","EFO_0000691","EFO_0000569","EFO_0000519"],"count":45},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 approved and 37 investigational indications."}
{"id":"CHEMBL195393","canonicalSmiles":"Nc1ncccc1OCc1cccc2ccccc12","inchiKey":"SZANYTFSQVBOBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL195393","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200435","canonicalSmiles":"CN(CCOc1ccc(-c2ccc(C#N)cc2)cc1)C(=O)NO","inchiKey":"GVMUNGGWXRKCEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200435","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06971"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL202932","canonicalSmiles":"COc1ccc(-c2ccc(S(=O)(=O)N[C@@H](C(C)C)P(=O)(O)O)cc2)cc1","inchiKey":"BZVYQWLRCHLAGK-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202932","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07772"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2029988","canonicalSmiles":"COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC","inchiKey":"DKNUPRMJNUQNHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-32496","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB-024","AC-013773","Agerafenib","CEP-32496","Cep-32496","RXDX-105","Rxdx 105"],"crossReferences":{"drugbank":["DB15068"]},"childChemblIds":["CHEMBL3309923"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000165731","ENSG00000157764"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL207197","canonicalSmiles":"NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N2Cc3ccccc3NC2=O)CC1)C(=O)N1CCN(c2ccncc2)CC1","inchiKey":"ITIXDWVDFFXNEG-JHOUSYSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLCEGEPANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIBN 4096 BS","BIBN-4096 BS","BIBN-4096BS","Bibn 4096 bs","Bibn-4096bs","Olcegepant"],"crossReferences":{"drugbank":["DB04869"]},"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104514","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"RVEWUBJVAHOGKA-WOYAITHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGININE GLUTAMATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Modumate"],"synonyms":["Arginine glutamate","L-arginine l-glutamate (1:1)","L-arginine l-glutamate hydrate","NSC-122009"],"crossReferences":{"DrugCentral":["4358"],"drugbank":["DB13207"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2104605","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(CSCC(F)(F)F)NS2(=O)=O","inchiKey":"RINBGYCKMGDWPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPITHIAZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epithiazide","Epitizide","Flurese","NSC-108164","P-2105","Thiaver"],"crossReferences":{"drugbank":["DB13989"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105294","canonicalSmiles":"COc1ccc2[n-]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Na+]","inchiKey":"RYXPMWYHEBGTRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMEPRAZOLE SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1503","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Losec sodium"],"synonyms":["H 168/68 SODIUM","Omeprazole (as sodium)","Omeprazole sodium"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105748","canonicalSmiles":"COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1.O=C(O)CCC(=O)O","inchiKey":"QZRSNVSQLGRAID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUCALOPRIDE SUCCINATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL117287","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Motegrity","Resolor"],"synonyms":["Prucalopride (as succinate)","Prucalopride succinate","R-108512"],"crossReferences":{"DailyMed":["prucalopride%20succinate"]},"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["HP_0002019","MONDO_0002203"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for constipation disorder and constipation."}
{"id":"CHEMBL2106246","canonicalSmiles":"N/N=c1/ccc(C(N)=O)n[nH]1","inchiKey":"WRYZEGZNBYOMLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDRACARBAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydracarbazine","TH-2151"],"crossReferences":{"drugbank":["DB09243"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107815","canonicalSmiles":"CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O.OCCNCCO","inchiKey":"RHWRWEUCEXUUAV-ZSESPEEFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREPROSTINIL DIOLAMINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237119","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orenitram","Ut-15c"],"synonyms":["Treprostinil diethanolamine","Treprostinil diolamin","Treprostinil diolamine","UT-15C"],"crossReferences":{"DailyMed":["treprostinil%20diolamine"]},"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000717"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 2 investigational indications."}
{"id":"CHEMBL2108021","drugType":"Antibody","blackBoxWarning":false,"name":"BESILESOMAB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Scintimun"],"synonyms":["BW250/183","Besilesomab","Besilesomab (99m-tc)","Technetium (99mtc) besilesomab","Technetium tc 99m besilesomab","Technetium tc-99m besilesomab"],"crossReferences":{"DrugCentral":["5086"]},"description":"Antibody drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108583","drugType":"Protein","blackBoxWarning":false,"name":"CINTREDEKIN BESUDOTOX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cintredekin besudotox","IL-13-PE38","IL13-PE38","IL13-PE38QQR"],"linkedTargets":{"rows":["ENSG00000123496","ENSG00000131724","ENSG00000077238"],"count":3},"linkedDiseases":{"rows":["EFO_0000630","MONDO_0100342","EFO_0000326","EFO_0002499","EFO_0002501","EFO_0003833","EFO_0000519","EFO_1000158"],"count":8},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2109181","drugType":"Antibody","blackBoxWarning":false,"name":"NEBACUMAB","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Spain"],"year":1993},"tradeNames":["Centoxin"],"synonyms":["CENTOXIN","HA 1A","HA-1A","Nebacumab","SEPTOMONAB","Septomonab"],"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 1991. It was withdrawn in United Kingdom and  Spain initially in 1993."}
{"id":"CHEMBL2109573","drugType":"Antibody","blackBoxWarning":false,"name":"GSK-249320","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-249320","Gsk-249320"],"linkedTargets":{"rows":["ENSG00000105695"],"count":1},"linkedDiseases":{"rows":["EFO_0000712"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2111187","canonicalSmiles":"[Cl-].[Cl-].[Ra+2]","inchiKey":"RWRDJVNMSZYMDV-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"RADIUM DICHLORIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Radium dichloride"],"crossReferences":{"DailyMed":["radium%20ra-223%20dichloride"]},"childChemblIds":["CHEMBL2107816"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 6 approved and 6 investigational indications."}
{"id":"CHEMBL213661","canonicalSmiles":"OC[C@H]1CN(CCCc2ccccc2)C[C@@H](O)[C@@H]1O","inchiKey":"NKARZGURZMIRMA-RBSFLKMASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL213661","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07807"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL22150","canonicalSmiles":"CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"WFNAKBGANONZEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORCYCLIZINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alergicide","COMPD 47-282","Chlorcyclizine","NSC-25246","Perazyl","Trihistan"],"crossReferences":{"Wikipedia":["Chlorcyclizine"],"drugbank":["DB08936"]},"childChemblIds":["CHEMBL1889091"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2220427","canonicalSmiles":"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C","inchiKey":"TYQXKHPOXXXCTP-CSLYCKPJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN PROPIONATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Erythromycin propionate","Erythromycin, 2'-propionate","Monopropionylerythromycin","Propiocine"],"crossReferences":{"PubChem":["144206740","170465433"],"chEBI":["48913"]},"childChemblIds":["CHEMBL2218877"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967."}
{"id":"CHEMBL227529","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O.O=C(O)c1ccccc1","inchiKey":"KEJICOXJTRHYAK-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOGLIPTIN BENZOATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL376359","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nesina"],"synonyms":["Alogliptin (as benzoate)","Alogliptin benzoate","SYR 322","SYR-322"],"crossReferences":{"DailyMed":["alogliptin%20benzoate"],"chEBI":["72324"]},"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013 and is indicated for type 2 diabetes mellitus."}
{"id":"CHEMBL2403108","canonicalSmiles":"Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1","inchiKey":"VERWOWGGCGHDQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERITINIB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zykadia"],"synonyms":["Ceritinib","Ceritinib[mi]","LDK-378","LDK378","NVP-LDK-378-NX","NVP-LDK378-NX"],"crossReferences":{"DailyMed":["ceritinib"],"drugbank":["DB09063"],"chEBI":["78432"]},"childChemblIds":["CHEMBL4476089","CHEMBL4468931","CHEMBL4542506"],"linkedTargets":{"rows":["ENSG00000171094","ENSG00000181163","ENSG00000143924"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002108","EFO_0000756","EFO_1001968","EFO_0003060","EFO_0005221","EFO_0000621","EFO_0000311","EFO_1000044","EFO_0003032","EFO_0000389","EFO_0001421","MONDO_0015798","EFO_0000519"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL240355","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccc2c(c1)N(CCNC(C)=O)C(=O)C(C)(C)O2","inchiKey":"GBXSOZDYCSBLQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL240355","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07059"]},"childChemblIds":["CHEMBL4081321"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253969","canonicalSmiles":"NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1","inchiKey":"HXHAJRMTJXHJJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSI-632","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-547,632","CP-547632","CP-632","Cp-547,632","Cp-547632","OSI-632","Osi-632","PAN 90806","PAN-90806","PAN90806"],"crossReferences":{"PubChem":["103905622","137275944"],"drugbank":["DB12962"]},"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","EFO_0001365","MONDO_0021117","MONDO_0008170","EFO_0003770","MONDO_0002087"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL257978","canonicalSmiles":"Cc1c(OCC2=NCCN2)ccc(Cl)c1NS(C)(=O)=O","inchiKey":"FOYWMEJSRSBQGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DABUZALGRON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dabuzalgron","Ro 115-1240","Ro-115-1240"],"childChemblIds":["CHEMBL2107325"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL260880","canonicalSmiles":"O=P(O)(O)C(O)(COc1cccc(-c2cccc(-c3ccccc3)c2)c1)P(=O)(O)O","inchiKey":"NWIARQRYIRVYCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[1-Hydroxy-2-(1,1':3',1''-Terphenyl-3-Yloxy)Ethane-1,1-Diyl]Bis(Phosphonic Acid)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[1-Hydroxy-2-(1,1':3',1''-Terphenyl-3-Yloxy)Ethane-1,1-Diyl]Bis(Phosphonic Acid)"],"crossReferences":{"drugbank":["DB07426"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL26424","canonicalSmiles":"CCN(CC)CCOc1ccc(Cc2ccccc2)cc1","inchiKey":"NFIXBCVWIPOYCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESMILIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tesmilifene"],"crossReferences":{"PubChem":["11113676","144204475","170466289","174007210","26751862"],"drugbank":["DB04905"]},"childChemblIds":["CHEMBL2107467"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL27551","canonicalSmiles":"O=CC(Cl)(Cl)Cl","inchiKey":"HFFLGKNGCAIQMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Trichloro-Acetaldehyde","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trichloro-Acetaldehyde"],"crossReferences":{"drugbank":["DB02650"],"chEBI":["48814"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL288436","canonicalSmiles":"Cc1cc2c(cc1C1(c3ccc(C(=O)O)cn3)CC1)C(C)(C)CCC2(C)C","inchiKey":"SLXTWXQUEZSSTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL288436","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137275854"],"drugbank":["DB01941"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL302795","canonicalSmiles":"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O","inchiKey":"LZNWYQJJBLGYLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOXICAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mobiflex"],"synonyms":["NSC-758397","RO 12-0068","RO 12-0068/000","RO-120068000","Tenoxicam","Tilcotil"],"crossReferences":{"PubChem":["11112804","11533043","144204217","170465677","56423650"],"drugbank":["DB00469"],"chEBI":["32192"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 1 investigational indication."}
{"id":"CHEMBL306280","canonicalSmiles":"CC[C@@]1(O)CC(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(F)c(F)cc3nc2-1","inchiKey":"LFQCJSBXBZRMTN-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLOMOTECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diflomotecan"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000702"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3098771","canonicalSmiles":"CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\\CCCc2ccccc21","inchiKey":"PPGNMFUMZSAZCW-VOYUZAMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UAB-30","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(9z)-uab-30","9-CIS-UAB30","9CUAB30","Retinoid 9cuab30","UAB-30","Uab-30","Uab30"],"crossReferences":{"drugbank":["DB12316"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137336","canonicalSmiles":"Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl","inchiKey":"AXTAPYRUEKNRBA-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UPROSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Akt inhibitor gsk-2141795","Akt inhibitor gsk2141795","GSK-2141795C","GSK2141795","GSK2141795C","Gsk-2141795","Uprosertib"],"crossReferences":{"drugbank":["DB11969"]},"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000616","MONDO_0002974","EFO_0000756","EFO_0000222","EFO_0001378","EFO_0000305","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL314437","canonicalSmiles":"CCC1(c2cccc(O)c2)CCCCN(C)C1","inchiKey":"JLICHNCFTLFZJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPTAZINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["IL-22811","Meptazinol"],"crossReferences":{"Wikipedia":["Meptazinol"],"drugbank":["DB13478"]},"childChemblIds":["CHEMBL1477274"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for pain."}
{"id":"CHEMBL3275586","canonicalSmiles":"CC(CN1CCN(CCOCCO)CC1)CN1c2ccccc2Sc2ccccc21","inchiKey":"MSYUMPGNGDNTIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIXYRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dixyrazine","Dyxirazine","Esucos","J21.394B","UCB-3412"],"crossReferences":{"drugbank":["DB13784"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301608","canonicalSmiles":"Cc1nc(NNC(=O)[C@H](CC2CCCC2)CN(O)C=O)c(F)c(N2CCN3CCOC[C@@H]3C2)n1","inchiKey":"SWHNZGMQMGFQGW-MSOLQXFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANOPEPDEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1322322B","GSK1322322","GSK1322322B","Gsk-1322322","Gsk-322","Lanopepden"],"crossReferences":{"drugbank":["DB11912"]},"childChemblIds":["CHEMBL3301616"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3305965","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1cccc(S(=O)(=O)O)c1","inchiKey":"TWQWRHIQRAZHPR-XNXCGYEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3305965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14703"]},"childChemblIds":["CHEMBL3186892"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL345292","canonicalSmiles":"CCCCCCSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O","inchiKey":"HXJDWCWJDCOHDG-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL345292","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04132"],"chEBI":["27704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544951","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04531083","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-4531083","Pf-04531083"],"linkedTargets":{"rows":["ENSG00000185313"],"count":1},"linkedDiseases":{"rows":["HP_0012532","EFO_0010072"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545060","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"ZXBDZLHAHGPXIG-VTXLJDRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN GLUCEPTATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL532","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilotycin","Ilotycin gluceptate"],"synonyms":["Erythromycin gluceptate","Erythromycin glucoheptonate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3545243","drugType":"Small molecule","blackBoxWarning":false,"name":"AS-703988","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["As-703988","MSC-2015103B"],"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545293","drugType":"Small molecule","blackBoxWarning":false,"name":"FGF401","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fgf401"],"linkedTargets":{"rows":["ENSG00000160867"],"count":1},"linkedDiseases":{"rows":["EFO_0000182"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545377","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2606368","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly-2606368"],"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["MONDO_0008170","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3589904","canonicalSmiles":"COc1ccc(Cl)c(-c2ccc(NC(=O)c3ccnn3C)nc2N)c1","inchiKey":"ZRJGMDIPCQOGNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3589904","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707250","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-601927","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-601,927","Cp-601927"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707324","drugType":"Antibody","blackBoxWarning":false,"name":"UTOMILUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05082566","PF-5082566","Utomilumab"],"linkedTargets":{"rows":["ENSG00000049249"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000365","EFO_0001075","EFO_0000096","EFO_0000403","MONDO_0007254","EFO_0000196","MONDO_0018906","EFO_0000305","EFO_0000311"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3707446","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"VXBNTHRZPJLRSS-PTCSXESPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVIPANSEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GMI-1070","PF-06460031","Rivipansel"],"crossReferences":{"drugbank":["DB12778"]},"childChemblIds":["CHEMBL3833316"],"linkedTargets":{"rows":["ENSG00000188404","ENSG00000174175","ENSG00000007908"],"count":3},"linkedDiseases":{"rows":["EFO_0003086","Orphanet_232","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL37387","canonicalSmiles":"Nc1nc(O)c(Br)c(-c2ccccc2)n1","inchiKey":"CIUUIPMOFZIWIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROPIRIMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bropirimine","NSC-149027","U-54,461","U-54461"],"crossReferences":{"PubChem":["144206218","170465913"],"drugbank":["DB04168"],"chEBI":["31307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3793226","canonicalSmiles":"O=c1ccc2ccc(F)c3c2n1C[C@H]3CN1CCC(NCc2cc3c(nn2)OCCO3)CC1","inchiKey":"SRICOHRDRMZREQ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-945237","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK945237","Gsk-945237","Gsk945237"],"crossReferences":{"drugbank":["DB15345"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989403","canonicalSmiles":"Cc1cc(CC(=O)[O-])n(C)c1C(=O)c1ccc(Cl)cc1.O.O.[Na+]","inchiKey":"ZJXLSCXDGPDZOL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOMEPIRAC SODIUM","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL19490","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Spain"," Germany "],"classes":["Immune system toxicity"],"year":1983},"tradeNames":["Zomax"],"synonyms":["MCN-2783-21-98","NSC-757379","Zomaxin","Zomepirac sodium","Zomepirac sodium anhydrous","Zomepirac sodium salt dihydrate","Zopirac"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980. It was withdrawn in United States,  United Kingdom,  United States,  Spain and  Germany  initially in 1983 due to Immune system toxicity."}
{"id":"CHEMBL3989677","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"IUAXSWPNEQYKDR-GXTZACRKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HYDROCODONE BITARTRATE","yearOfFirstApproval":1943,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1457","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dicodid","Hysingla","Hysingla er","Mercodinone","Vantrela er","Zohydro er"],"synonyms":["CEP-33237","Dihydrocodeinone bitartrate","Hycodan","Hydrocodone bitartrate","Hydrocodone bitartrate cii","Hydrocodone bitartrate hemipentahydrate","Hydrocodone tartrate","Vantrela","Zohydro"],"crossReferences":{"DailyMed":["hydrocodone%20bitartrate"]},"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000546","EFO_0003086","EFO_0003890","HP_0012532","EFO_0001421","HP_0003419","EFO_0005611","EFO_0003843","MONDO_0005178","EFO_1001250"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1943 and is indicated for pain and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989849","canonicalSmiles":"C[N+]1(CC(=O)c2ccc(-c3ccccc3)cc2)[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@H](CO)c1ccccc1)C2","inchiKey":"CSYZZFNWCDOVIM-OCTNZTSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENTONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fentonium","Fentonium cation","Fentonium ion"],"crossReferences":{"drugbank":["DB08978"]},"childChemblIds":["CHEMBL3989580"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989873","canonicalSmiles":"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccc(I)cc4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"JTZRECOPNKCRTE-MOROJQBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICLIDENOSON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALB-7208","CF-101","CF101","Cf101","IB-MECA","Piclidenoson"],"linkedTargets":{"rows":["ENSG00000282608"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_1000986","EFO_1001069","MONDO_0100096","EFO_1000906","EFO_0000676","EFO_0004616","EFO_0000516","EFO_1001119"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3990044","drugType":"Antibody","blackBoxWarning":false,"name":"RELATLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986016","Relatlimab"],"linkedTargets":{"rows":["ENSG00000089692"],"count":1},"linkedDiseases":{"rows":["EFO_1001465","EFO_0001378","MONDO_0044881","EFO_0000519","EFO_1001951"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL401150","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]2C[C@H](n3ccc(=O)[nH]c3=O)O[C@@H]2COP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H]1O","inchiKey":"JIAJERGOUFOENU-LNAOLWRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401150","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03186"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL404216","canonicalSmiles":"CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21","inchiKey":"RUJBDQSFYCKFAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOFISOPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emandaxin","Tofisopam"],"crossReferences":{"PubChem":["144205822","29217670","50111721"],"Wikipedia":["Tofisopam"],"drugbank":["DB08811"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL409450","canonicalSmiles":"O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N/O","inchiKey":"DDLZLOKCJHBUHD-WAVHTBQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6BIO","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26753605","26753606","29215160","90341740"],"drugbank":["DB03444"],"chEBI":["86290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL41194","canonicalSmiles":"CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CCCC2","inchiKey":"KCTFTBCZZUBAKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRATOSARTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA-727","DA727","KT3-671","Kt-3671","Pratosartan"],"crossReferences":{"chEBI":["32041"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL419362","canonicalSmiles":"COC(=O)[C@H](Cc1ccc(C#Cc2ccccc2)cc1)NC(=O)C[C@H]1CCCN(C(=N)N)C1","inchiKey":"MRNGXYMKYHNMLV-PKTZIBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Ro-264550","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ro-264550"],"crossReferences":{"drugbank":["DB03453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428","canonicalSmiles":"N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12","inchiKey":"WVPSKSLAZQPAKQ-CDMJZVDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROVAFLOXACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-99219","Trovafloxacin"],"crossReferences":{"Wikipedia":["Trovafloxacin"],"drugbank":["DB00685"],"chEBI":["9763"]},"childChemblIds":["CHEMBL1200779"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL428963","canonicalSmiles":"Cc1nnc(-c2ccccc2Nc2ncnc3[nH]ccc23)[nH]1","inchiKey":"OKGCSZUKOGMZAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL428963","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07584"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297271","drugType":"Small molecule","blackBoxWarning":false,"name":"BMX-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bmx-001"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297374","canonicalSmiles":"CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"NHIUKVHKLJSJEA-LINJWFRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILADEMETAN TOSYLATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4292264","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-3032 TOSYLATE","DS-3032B","Ds 3032b","Ds-3032b","Milademetan tosylate"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297471","canonicalSmiles":"Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2cc3c(cn2)[C@@H]2[C@@H](C(=O)O)[C@@H]2C3)c1","inchiKey":"CODQKEMYZZKQAE-QPVYNBJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-8666","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8666","Mk-8666"],"crossReferences":{"drugbank":["DB14937"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297500","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC/C(=N\\O)[C@](C)(CCCO)[C@H]3CC[C@@]21C","inchiKey":"OBKBVSFXEIFOMS-YVABUZGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRO-40303","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRO 40303","TRO-40303","TRO40303","Tro-40303","Tro40303"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297691","drugType":"Unknown","blackBoxWarning":false,"name":"ALX-009","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alx-009","Meveol"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297783","drugType":"Antibody","blackBoxWarning":false,"name":"CLESROVIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clesrovimab","MK-1654","Mk-1654"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298185","drugType":"Protein","blackBoxWarning":false,"name":"LONAPEGSOMATROPIN","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Skytrofa","Stem-stat ortho"],"synonyms":["ACP-011","Lonapegsomatropin","Lonapegsomatropin-tcgd","TRANSCONPEG-HGH","TransConPEG hGh","rhGH-PEG"],"linkedTargets":{"rows":["ENSG00000112964"],"count":1},"linkedDiseases":{"rows":["EFO_1001109"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for pituitary dwarfism."}
{"id":"CHEMBL4303309","canonicalSmiles":"Cc1cnc(CNC(=O)c2c(=O)c3ccc(N4CCCN(C)CC4)nc3n3c2sc2ccccc23)cn1","inchiKey":"XGPBJCHFROADCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CX-5461","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX-5461","Cx-5461","Pidnarulex"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL444929","canonicalSmiles":"CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](NCCCNCCCCN)C[C@@H]1C[C@H]3O)OS(=O)(=O)O","inchiKey":"UIRKNQLZZXALBI-MSVGPLKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUALAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Squalamine"],"crossReferences":{"Wikipedia":["Squalamine"],"drugbank":["DB06461"],"chEBI":["80765"]},"childChemblIds":["CHEMBL3989689","CHEMBL2386601"],"linkedTargets":{"rows":["ENSG00000066230"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","EFO_0001365","MONDO_0008170","EFO_0003770","MONDO_0008315"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL448297","canonicalSmiles":"COc1cc(O)c2c(c1)O[C@H](c1ccc(O)cc1)CC2=O","inchiKey":"DJOJDHGQRNZXQQ-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAKURANETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-O-Methylnaringenin","Naringenin 7-Methyl Ether","Sakuranetin"],"crossReferences":{"Wikipedia":["Sakuranetin"],"drugbank":["DB08517"],"chEBI":["28927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594549","drugType":"Antibody","blackBoxWarning":false,"name":"PIMURUTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HLX-07","HLX07","Hlx07","Pimurutamab"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594607","drugType":"Enzyme","blackBoxWarning":false,"name":"APADAMTASE ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adamts13, recombinant human","Apadamtase alfa","BAX-930","Recombinant adamts-13","Recombinant human adamts13","SHP-655","SHP655","Shp655","TAK-755"],"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650445","drugType":"Unknown","blackBoxWarning":false,"name":"ASP-1951","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-1951","ASP1951","Asp-1951","Asp1951","PTZ-522"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650473","drugType":"Unknown","blackBoxWarning":false,"name":"IBI-939","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IBI-939","IBI939","Ibi-939","Ibi939","Tamgiblimab"],"linkedTargets":{"rows":["ENSG00000181847"],"count":1},"linkedDiseases":{"rows":["MONDO_0008903","EFO_0000311"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650515","drugType":"Unknown","blackBoxWarning":false,"name":"CEP-40783","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-40783","Cep-40783","RXDX-106","Rxdx-106"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL476323","canonicalSmiles":"Cc1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1","inchiKey":"DDDZBLNULGDPGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0249","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0249","MK0249","Mk-0249"],"crossReferences":{"drugbank":["DB11910"]},"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","HP_0000726","MONDO_0004975","EFO_0003918"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4802182","drugType":"Unknown","blackBoxWarning":false,"name":"THR-18","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thr-18"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL48361","canonicalSmiles":"Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21","inchiKey":"YBSJFWOBGCMAKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DABIGATRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pradaxa"],"synonyms":["BIBR 953 ZW","BIBR-953","BIBR-953-ZW","Dabigatran","Pradaxa (dabigatran)"],"crossReferences":{"PubChem":["174006835"],"Wikipedia":["Dabigatran"],"drugbank":["DB14726"],"chEBI":["70752"]},"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["HP_0002140","EFO_0000275","EFO_0001645","EFO_0004286","EFO_1001413","HP_0001907","HP_0000083","EFO_0000546","MP_0001914","EFO_0010680","EFO_0003827","EFO_0000712","Orphanet_136","EFO_0000400"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL491429","canonicalSmiles":"O=C(Nc1cncnc1)c1c(Cl)ccc2c(Nc3cccc(C(F)(F)F)c3)noc12","inchiKey":"FEGRQUWSKADGSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL491429","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07326"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL514800","canonicalSmiles":"CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC","inchiKey":"IMOZEMNVLZVGJZ-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APREMILAST","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Otezla"],"synonyms":["Apremilast","CC-10004","CC10004"],"crossReferences":{"DailyMed":["apremilast"],"drugbank":["DB05676"],"chEBI":["78540"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["HP_0000155","EFO_0000729","EFO_1000668","EFO_1000710","EFO_1001494","EFO_0003780","EFO_0004274","EFO_0003778","EFO_0000274","EFO_1000747","EFO_0000540","Orphanet_163927","HP_0012219","EFO_0000676","EFO_0004208","EFO_1000789","MONDO_0007079","EFO_1000726","EFO_0008517","EFO_0000685","MONDO_0026045","HP_0000964","MONDO_0022113","EFO_0003898","MONDO_0019558","EFO_0003894","EFO_0003106","EFO_0009855","EFO_1000760","EFO_1001231","MONDO_0100096","EFO_0000398","MONDO_0002406","EFO_0007328","EFO_0003830","HP_0011107"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 5 approved and 22 investigational indications."}
{"id":"CHEMBL54481","canonicalSmiles":"O=C(O)c1cc(O)c2c(c1)C(C1c3cc(C(=O)O)cc(O)c3C(=O)c3c(OC4OC(CO)C(O)C(O)C4O)cccc31)c1cccc(OC3OC(CO)C(O)C(O)C3O)c1C2=O","inchiKey":"IPQVTOJGNYVQEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL54481","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["555084","555085"],"drugbank":["DB11365"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559180","canonicalSmiles":"CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl","inchiKey":"QVPSGVSNYPRFAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOXSUPRINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1197051","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Defencin","Duvadilan","Duvadilan ret","Vasodilan"],"synonyms":["Dilavase","Duviculine","Isoxsuprine hcl","Isoxsuprine hydrochloride","NSC-757067","Navilox","Suprilent","Vadosilan","Vasotran"],"crossReferences":{"PubChem":["144204018","170465968","26748094","56422878","855622"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":4},"linkedDiseases":{"rows":["MONDO_0005301"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL583912","canonicalSmiles":"Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2","inchiKey":"PFTAWBLQPZVEMU-UKRRQHHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-EPICATECHIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-epi catechin","(-)-epicatechin","(-)-epicatechol","Epi-catechin","Epi-catechol","Epicatechin","Epicatechol","L-acacatechin","L-epicatechin","NSC-81161"],"crossReferences":{"PubChem":["11110917","11112309","11112310","144203652","170465932","50086732","81066101"],"drugbank":["DB12039"],"chEBI":["90"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL6685","canonicalSmiles":"NS(=O)(=O)c1nc2ccc(O)cc2s1","inchiKey":"NOOBQTYVTDBXTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL6685","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08765"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL689","canonicalSmiles":"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"FBPFZTCFMRRESA-KVTDHHQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANNITOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aridol kit","Bronchitol","Diosmol","Mannite","Mannitol","Osmitrol","Resectisol"],"synonyms":["Alexitol sodium","Cordycepic acid","Crystalline mannitol extra-fine","Crystalline mannitol fine","Crystalline mannitol standard","D-(-)-mannitol","D-mannitol","E-421","E421","INS NO.421","INS-421","Isomalt impurity, mannitol-","Manna sugar","Mannite","Mannitol","Mannitol 200","Mannitol 2080","Mannitol 25","Mannitol 300","Mannitol 35","Mannitol 60","Mannitol m300","Mannitol, d-","Mannitolum","Mannogem 2080","NSC-407017","Pearlitol 160 c","Pearlitol 200 sd","Pearlitol 25 c","Pearlitol 300 dc","Pearlitol 50 c"],"crossReferences":{"PubChem":["144205645","144208685","144210801","170465566","26757663","56322640"],"Wikipedia":["Mannitol"],"drugbank":["DB00742"],"chEBI":["16899"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 approved and 28 investigational indications."}
{"id":"CHEMBL6995","canonicalSmiles":"CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1","inchiKey":"DURULFYMVIFBIR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRACTOLOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eraldin"],"synonyms":["AY-21,011","AY-21011","Dalzic","I.C.I. 50,172","I.C.I.-50,172","ICI-50172","Practolol","[3-(4-Acetylamino-Phenoxy)-2-Hydroxy-Propyl]-Isopropyl-Ammonium"],"crossReferences":{"PubChem":["144204479","170466619","56463034"],"Wikipedia":["Practolol"],"drugbank":["DB01297"],"chEBI":["258351"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL70927","canonicalSmiles":"Cc1c(O)c(=O)ccn1C","inchiKey":"TZXKOCQBRNJULO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DEFERIPRONE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ferriprox"],"synonyms":["APO-066","APO-66","CP-20","CP20","DN-180-01-AF","DN-18001AF","Deferipron","Deferiprone","L-1","L1","NSC-758880","PL-1","PL1"],"crossReferences":{"DailyMed":["deferiprone"],"PubChem":["104233432","144205982","26719648","26752603","8139956"],"Wikipedia":["Deferiprone"],"drugbank":["DB08826"],"chEBI":["68554"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for thalassemia and sickle cell anemia and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL8085","canonicalSmiles":"NCCCC[C@H](N)C(=O)O","inchiKey":"KDXKERNSBIXSRK-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LYSINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lysine"],"crossReferences":{"PubChem":["29218054"],"drugbank":["DB00123"],"chEBI":["18019"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL849","canonicalSmiles":"Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl","inchiKey":"XEFQLINVKFYRCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLOSAN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquasept","Gamophen","Innoxa","Manusept","Skinsan","Stri-dex cleansing bar","Stri-dex face wash","Tegusept"],"synonyms":["CH 3565","CH-3565","Cloxifenol","DNDI1246774","NSC-759151","Triclosan"],"crossReferences":{"PubChem":["144205201","144214040","170464936","174006648","26754498","29215355","49674565","57260157"],"Wikipedia":["Triclosan"],"drugbank":["DB08604"],"chEBI":["164200"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 5 investigational indications."}
{"id":"CHEMBL92361","canonicalSmiles":"O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12","inchiKey":"INSBKYCYLCEBOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CGP-029482","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP-029482"],"crossReferences":{"drugbank":["DB01765"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9940","canonicalSmiles":"CN(C)CCNC(=O)c1cccc2cc3ccccc3nc12","inchiKey":"XBGNERSKEKDZDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSC-601316","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-601316"],"crossReferences":{"drugbank":["DB11880"]},"childChemblIds":["CHEMBL1204136"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
